CRHBP (22-322), Human

Corticotropin Releasing Hormone Binding Protein (22-322 a.a.) Human Recombinant
Cat. No.
BT21699
Source

Escherichia Coli.

Synonyms

Corticotropin releasing hormone binding protein, CRF-BP, CRH-BP, CRF-binding protein.

Appearance
Sterile Filtered colorless solution.
Purity

Greater than 85.0% as determined by SDS-PAGE.

Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

CRHBP Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 324 amino acids (22-322 a.a) and having a molecular mass of 36.1kDa.
CRHBP is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Product Specs

Introduction
Corticotropin Releasing Hormone Binding Protein (CRHBP) stimulates the secretion and synthesis of preopiomelanocortin-derived peptides. Plasma CRHBP levels are typically low but increase significantly during pregnancy, likely originating from the placenta. After childbirth, CRHBP levels return to normal. This protein inactivates CRH in the bloodstream, preventing excessive stimulation of the pituitary-adrenal axis during pregnancy.
Description
Recombinant Human CRHBP, expressed in E. coli, is a single, non-glycosylated polypeptide chain encompassing amino acids 22-322. A 23 amino acid His-tag is fused to the N-terminus. The protein has a molecular weight of 36.1 kDa and is purified using proprietary chromatographic techniques.
Physical Appearance
Clear, colorless and sterile-filtered solution.
Formulation
CRHBP protein is provided at a concentration of 1mg/ml in a buffer consisting of 10% glycerol, 0.4M urea, and 20mM Tris-HCl at pH 8.0.
Stability
For short-term storage (up to 4 weeks), the product can be stored at 4°C. For extended storage, freezing at -20°C is recommended. Adding a carrier protein like HSA or BSA (0.1%) is advised for long-term storage. Repeated freezing and thawing should be avoided.
Purity
The purity is determined to be greater than 85.0% via SDS-PAGE analysis.
Synonyms

Corticotropin releasing hormone binding protein, CRF-BP, CRH-BP, CRF-binding protein.

Source

Escherichia Coli.

Amino Acid Sequence

MGSSHHHHHH SSGLVPRGSH MGSESRYLEL REAADYDPFL LFSANLKREL AGEQPYRRAL RCLDMLSLQG QFTFTADRPQ LHCAAFFISE PEEFITIHYD QVSIDCQGGD FLKVFDGWIL KGEKFPSSQD HPLPSAERYI DFCESGLSRR SIRSSQNVAM IFFRVHEPGN GFTLTIKTDP NLFPCNVISQ TPNGKFTLVV PHQHRNCSFS IIYPVVIKIS DLTLGHVNGL QLKKSSAGCE GIGDFVELLG GTGLDPSKMT PLADLCYPFH GPAQMKVGCD NTVVRMVSSG KHVNRVTFEY RQLEPYELEN PNGNSIGEFC LSGL

Product Science Overview

Introduction

Corticotropin Releasing Hormone Binding Protein (CRHBP) is a crucial protein involved in the regulation of the hypothalamic-pituitary-adrenal (HPA) axis. This protein binds to Corticotropin Releasing Hormone (CRH), modulating its bioavailability and activity. The recombinant form of CRHBP, specifically the 22-322 amino acid sequence, is a significant tool in research and therapeutic applications.

Structure and Function

CRHBP is a protein coding gene that plays a pivotal role in the HPA axis by binding to CRH. This binding inactivates CRH, preventing inappropriate pituitary-adrenal stimulation, especially during pregnancy . The protein’s structure allows it to interact with CRH effectively, ensuring the proper regulation of stress responses and other physiological processes.

Biological Role

CRHBP is essential in maintaining the balance of CRH levels in the body. CRH is a potent stimulator of the synthesis and secretion of adrenocorticotropic hormone (ACTH) from the pituitary gland. By binding to CRH, CRHBP regulates its availability, thus controlling the downstream effects on cortisol release and other stress-related hormones .

Clinical Significance

The dysregulation of CRHBP has been associated with various diseases and conditions. For instance, aberrant hypermethylation and silencing of the CRHBP gene have been observed in acute myeloid leukemia (AML), suggesting its role as a tumor suppressor . Additionally, changes in CRHBP levels have been linked to conditions such as muscular dystrophy-dystroglycanopathy and primary hyperaldosteronism .

Recombinant CRHBP (22-322 a.a.)

The recombinant form of CRHBP, particularly the 22-322 amino acid sequence, is used extensively in research to study its interactions with CRH and its role in various physiological and pathological processes. This recombinant protein is produced using advanced biotechnological methods, ensuring high purity and activity for experimental applications.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.